Biontech Faces Dual Crisis: Works Council Alleges Toxic Culture as 1,800 Jobs Hang in the Balance

A confidential letter delivered to Biontech's board on 2 November 2026 has thrown the Mainz-based vaccine maker into turmoil. In the sharply worded document, the company's works council accused management of serious failings in its treatment of employees, citing toxic working conditions and egregious misconduct within the organisation.

According to media reports, the council's complaint references specific allegations of discrimination, sexism, racism and threats. None of these claims has yet been independently verified.

Demands for Safe Reporting Channels and Greater Transparency

The works council is pressing Biontech's leadership to establish confidential contact points for affected staff without delay. It is also calling for significantly more transparency around the restructuring process already under way.

Management responded by saying it takes the allegations very seriously and stressed that discrimination of any kind is not tolerated within the group. Biontech further made clear that whistleblowers who raise grievances have nothing to fear in terms of retaliation.

Sweeping Restructuring and Site Closures

The allegations land as the biotechnology company undergoes deep cuts. Up to 1,800 positions are set to disappear as part of a comprehensive corporate overhaul.

Several German sites are also slated for closure: the Tübingen location is to be abandoned at the end of 2027, the Marburg facility at the beginning of 2028, and the Idar-Oberstein plant at the end of 2028. A dispute is already simmering between management and employee representatives over the size and structure of severance packages for affected staff.

On top of this, the Mainz company is preparing for a historic leadership transition. Founding couple Ugur Sahin and Özlem Türeci intend to leave Biontech in the coming weeks. A successor is already lined up: Guido Oelkers is to take over as chief executive no later than 1 February 2027.

What German Labour Law Requires of the Board

In light of the allegations, industry reports point to the strict statutory duties employers bear under German labour law.

Section 12 of the General Equal Treatment Act (AGG) obliges employers to take effective measures against discrimination, while Section 16 AGG sets out a clear prohibition on disadvantaging employees who assert their rights.

Under Section 5(3) No. 6 of the Occupational Health and Safety Act, companies must also factor psychological stress into their workplace risk assessments.

For a company of this size, the Whistleblower Protection Act additionally applies, requiring an internal reporting channel under Section 12 once an organisation reaches 50 employees.

Should allegations against individual managers or staff members be substantiated, Section 626(2) of the Civil Code imposes a strict two-week deadline from the point of knowledge of the relevant facts for any extraordinary dismissal. The board now faces the task of investigating the claims while simultaneously steering the workforce through the impending job cuts.